According to the research report, the global market for Benign Prostatic Hyperplasia (BPH) Laser Therapy should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Benign Prostatic Hyperplasia (BPH) Laser Therapy market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Benign Prostatic Hyperplasia (BPH) Laser Therapy market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Hospitals grew percent to account for percent of the total market sales, and Clinics grew percent.
BPH or benign prostatic hyperplasia or hypertrophy is a benign enlargement of the prostate.BPH Laser Therapy is a minimally invasive procedure for BPH (benign prostatic hyperplasia) that uses laser energy to remove enlarged prostate tissue, resulting in an open channel for urine flow-through and a quick return to a life with dramatically improved BPH symptoms.Benign prostate hyperplasia (BPH), while not cancer, can causes symptoms such as bladder stones, blood in the urine and an inability to urinate.
This report studies and analyses global Benign Prostatic Hyperplasia (BPH) Laser Therapy status and future trends, to help determine the Benign Prostatic Hyperplasia (BPH) Laser Therapy market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Benign Prostatic Hyperplasia (BPH) Laser Therapy, and provides market size (US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Benign Prostatic Hyperplasia (BPH) Laser Therapy market size, history data 2018-2023, and forecast data 2024-2029, (US$ million)
(2) Global Benign Prostatic Hyperplasia (BPH) Laser Therapy by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(3) China Benign Prostatic Hyperplasia (BPH) Laser Therapy by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(4) Global Benign Prostatic Hyperplasia (BPH) Laser Therapy key consuming regions, consumption value and demand structure
(5) Benign Prostatic Hyperplasia (BPH) Laser Therapy industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Boston Scientific
Agiliti Health, Inc.
Endo Pharmaceuticals Inc.
HealthTronics, Inc.
OmniGuide
Olympus Corporation
Richard Wolf GmbH
Lumenis
Urologix, LLC
Coloplast Corp
Medifocus Inc.
Biolitec
Teleflex Incorporated
Urotech Devices
BD
PROCEPT BioRobotics
Market segment by Type, covers
Holmium Laser
Thulium Laser
Green Light Laser
Others
Market segment by Application, can be divided into
Hospitals
Clinics
Others
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Benign Prostatic Hyperplasia (BPH) Laser Therapy product scope, global consumption value, China consumption value, development opportunities, challenges, trends, and policies.
Chapter 2: Global Benign Prostatic Hyperplasia (BPH) Laser Therapy market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 3: China Benign Prostatic Hyperplasia (BPH) Laser Therapy market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 4: Benign Prostatic Hyperplasia (BPH) Laser Therapy industry chain, upstream, medium-stream, and downstream.
Chapter 5: Segment by Type, consumption value, percent & CAGR, 2018-2029
Chapter 6: Segment by Application, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in country level, consumption value, percent & CAGR, 2018-2029
Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin.
Chapter 10: Conclusions
1 Market Overview
1.1 Benign Prostatic Hyperplasia (BPH) Laser Therapy Definition
1.2 Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Size and Forecast
1.3 China Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Size and Forecast
1.4 China Percentage in Global Market
1.5 Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Size: China VS Global Growth Rate, 2018-2029
1.6 Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Dynamics
1.6.1 Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Drivers
1.6.2 Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Restraints
1.6.3 Benign Prostatic Hyperplasia (BPH) Laser Therapy Industry Trends
1.6.4 Benign Prostatic Hyperplasia (BPH) Laser Therapy Industry Policy
2 Global Leading Players and Market Share
2.1 By Revenue of Benign Prostatic Hyperplasia (BPH) Laser Therapy, Global Market Share by Company, 2018-2023
2.2 Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Concentration Ratio
2.4 Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Mergers & Acquisitions, Expansion Plans
2.5 Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Major Companies Product Type
2.6 Head Office and Benign Prostatic Hyperplasia (BPH) Laser Therapy Production Site of Key Manufacturer
3 China Leading Players, Market Share and Ranking
3.1 By Revenue of Benign Prostatic Hyperplasia (BPH) Laser Therapy, China Market Share by Company, 2018-2023
3.2 China Benign Prostatic Hyperplasia (BPH) Laser Therapy Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Industry Chain Analysis
4.1 Benign Prostatic Hyperplasia (BPH) Laser Therapy Industry Chain
4.2 Benign Prostatic Hyperplasia (BPH) Laser Therapy Upstream Analysis
4.2.1 Benign Prostatic Hyperplasia (BPH) Laser Therapy Core Raw Materials
4.2.2 Main Manufacturers of Benign Prostatic Hyperplasia (BPH) Laser Therapy Core Raw Materials
4.3 Midstream Analysis
4.4 Downstream Analysis
4.5 Benign Prostatic Hyperplasia (BPH) Laser Therapy Production Mode
4.6 Benign Prostatic Hyperplasia (BPH) Laser Therapy Procurement Model
4.7 Benign Prostatic Hyperplasia (BPH) Laser Therapy Industry Sales Model and Sales Channels
4.7.1 Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Model
4.7.2 Benign Prostatic Hyperplasia (BPH) Laser Therapy Typical Distributors
5 Sights by Type
5.1 Benign Prostatic Hyperplasia (BPH) Laser Therapy Classification
5.1.1 Holmium Laser
5.1.2 Thulium Laser
5.1.3 Green Light Laser
5.1.4 Others
5.2 By Type, Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value, 2018-2029
6 Sights by Application
6.1 Benign Prostatic Hyperplasia (BPH) Laser Therapy Segment by Application
6.1.1 Hospitals
6.1.2 Clinics
6.1.3 Others
6.2 By Application, Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value, 2018-2029
7 Sales Sights by Region
7.1 By Region, Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value, 2018 VS 2022 VS 2029
7.2 By Region, Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value, 2018-2029
7.3 North America
7.3.1 North America Benign Prostatic Hyperplasia (BPH) Laser Therapy & Forecasts, 2018-2029
7.3.2 By Country, North America Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Size Market Share
7.4 Europe
7.4.1 Europe Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Size Market Share
7.6 South America
7.6.1 South America Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Size Market Share
7.7 Middle East & Africa
8 Sales Sights by Country Level
8.1 By Country, Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Size & CAGR, 2018 VS 2022 VS 2029
8.2 By Country, Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value, 2018-2029
8.3 U.S.
8.3.1 U.S. Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Size, 2018-2029
8.3.2 By Type, U.S. Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value Market Share, 2022 VS 2029
8.3.3 By Application, U.S. Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Size, 2018-2029
8.4.2 By Type, Europe Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value Market Share, 2022 VS 2029
8.4.3 By Application, Europe Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value Market Share, 2022 VS 2029
8.5 China
8.5.1 China Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Size, 2018-2029
8.5.2 By Type, China Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value Market Share, 2022 VS 2029
8.5.3 By Application, China Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Size, 2018-2029
8.6.2 By Type, Japan Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value Market Share, 2022 VS 2029
8.6.3 By Application, Japan Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Size, 2018-2029
8.7.2 By Type, South Korea Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value Market Share, 2022 VS 2029
8.7.3 By Application, South Korea Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Size, 2018-2029
8.8.2 By Type, Southeast Asia Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value Market Share, 2022 VS 2029
8.8.3 By Application, Southeast Asia Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value Market Share, 2022 VS 2029
8.9 India
8.9.1 India Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Size, 2018-2029
8.9.2 By Type, India Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value Market Share, 2022 VS 2029
8.9.3 By Application, India Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value Market Share, 2022 VS 2029
8.10 Middle East & Africa
8.10.1 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Size, 2018-2029
8.10.2 By Type, Middle East & Africa Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value Market Share, 2022 VS 2029
8.10.3 By Application, Middle East & Africa Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value Market Share, 2022 VS 2029
9 Company Profile
9.1 Boston Scientific
9.1.1 Boston Scientific Company Information, Head Office, Market Area and Industry Position
9.1.2 Boston Scientific Company Profile and Main Business
9.1.3 Boston Scientific Benign Prostatic Hyperplasia (BPH) Laser Therapy Models, Specifications and Application
9.1.4 Boston Scientific Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Gross Margin, 2018-2023
9.1.5 Boston Scientific Recent Developments
9.2 Agiliti Health, Inc.
9.2.1 Agiliti Health, Inc. Company Information, Head Office, Market Area and Industry Position
9.2.2 Agiliti Health, Inc. Company Profile and Main Business
9.2.3 Agiliti Health, Inc. Benign Prostatic Hyperplasia (BPH) Laser Therapy Models, Specifications and Application
9.2.4 Agiliti Health, Inc. Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Gross Margin, 2018-2023
9.2.5 Agiliti Health, Inc. Recent Developments
9.3 Endo Pharmaceuticals Inc.
9.3.1 Endo Pharmaceuticals Inc. Company Information, Head Office, Market Area and Industry Position
9.3.2 Endo Pharmaceuticals Inc. Company Profile and Main Business
9.3.3 Endo Pharmaceuticals Inc. Benign Prostatic Hyperplasia (BPH) Laser Therapy Models, Specifications and Application
9.3.4 Endo Pharmaceuticals Inc. Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Gross Margin, 2018-2023
9.3.5 Endo Pharmaceuticals Inc. Recent Developments
9.4 HealthTronics, Inc.
9.4.1 HealthTronics, Inc. Company Information, Head Office, Market Area and Industry Position
9.4.2 HealthTronics, Inc. Company Profile and Main Business
9.4.3 HealthTronics, Inc. Benign Prostatic Hyperplasia (BPH) Laser Therapy Models, Specifications and Application
9.4.4 HealthTronics, Inc. Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Gross Margin, 2018-2023
9.4.5 HealthTronics, Inc. Recent Developments
9.5 OmniGuide
9.5.1 OmniGuide Company Information, Head Office, Market Area and Industry Position
9.5.2 OmniGuide Company Profile and Main Business
9.5.3 OmniGuide Benign Prostatic Hyperplasia (BPH) Laser Therapy Models, Specifications and Application
9.5.4 OmniGuide Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Gross Margin, 2018-2023
9.5.5 OmniGuide Recent Developments
9.6 Olympus Corporation
9.6.1 Olympus Corporation Company Information, Head Office, Market Area and Industry Position
9.6.2 Olympus Corporation Company Profile and Main Business
9.6.3 Olympus Corporation Benign Prostatic Hyperplasia (BPH) Laser Therapy Models, Specifications and Application
9.6.4 Olympus Corporation Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Gross Margin, 2018-2023
9.6.5 Olympus Corporation Recent Developments
9.7 Richard Wolf GmbH
9.7.1 Richard Wolf GmbH Company Information, Head Office, Market Area and Industry Position
9.7.2 Richard Wolf GmbH Company Profile and Main Business
9.7.3 Richard Wolf GmbH Benign Prostatic Hyperplasia (BPH) Laser Therapy Models, Specifications and Application
9.7.4 Richard Wolf GmbH Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Gross Margin, 2018-2023
9.7.5 Richard Wolf GmbH Recent Developments
9.8 Lumenis
9.8.1 Lumenis Company Information, Head Office, Market Area and Industry Position
9.8.2 Lumenis Company Profile and Main Business
9.8.3 Lumenis Benign Prostatic Hyperplasia (BPH) Laser Therapy Models, Specifications and Application
9.8.4 Lumenis Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Gross Margin, 2018-2023
9.8.5 Lumenis Recent Developments
9.9 Urologix, LLC
9.9.1 Urologix, LLC Company Information, Head Office, Market Area and Industry Position
9.9.2 Urologix, LLC Company Profile and Main Business
9.9.3 Urologix, LLC Benign Prostatic Hyperplasia (BPH) Laser Therapy Models, Specifications and Application
9.9.4 Urologix, LLC Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Gross Margin, 2018-2023
9.9.5 Urologix, LLC Recent Developments
9.10 Coloplast Corp
9.10.1 Coloplast Corp Company Information, Head Office, Market Area and Industry Position
9.10.2 Coloplast Corp Company Profile and Main Business
9.10.3 Coloplast Corp Benign Prostatic Hyperplasia (BPH) Laser Therapy Models, Specifications and Application
9.10.4 Coloplast Corp Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Gross Margin, 2018-2023
9.10.5 Coloplast Corp Recent Developments
9.11 Medifocus Inc.
9.11.1 Medifocus Inc. Company Information, Head Office, Market Area and Industry Position
9.11.2 Medifocus Inc. Company Profile and Main Business
9.11.3 Medifocus Inc. Benign Prostatic Hyperplasia (BPH) Laser Therapy Models, Specifications and Application
9.11.4 Medifocus Inc. Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Gross Margin, 2018-2023
9.11.5 Medifocus Inc. Recent Developments
9.12 Biolitec
9.12.1 Biolitec Company Information, Head Office, Market Area and Industry Position
9.12.2 Biolitec Company Profile and Main Business
9.12.3 Biolitec Benign Prostatic Hyperplasia (BPH) Laser Therapy Models, Specifications and Application
9.12.4 Biolitec Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Gross Margin, 2018-2023
9.12.5 Biolitec Recent Developments
9.13 Teleflex Incorporated
9.13.1 Teleflex Incorporated Company Information, Head Office, Market Area and Industry Position
9.13.2 Teleflex Incorporated Company Profile and Main Business
9.13.3 Teleflex Incorporated Benign Prostatic Hyperplasia (BPH) Laser Therapy Models, Specifications and Application
9.13.4 Teleflex Incorporated Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Gross Margin, 2018-2023
9.13.5 Teleflex Incorporated Recent Developments
9.14 Urotech Devices
9.14.1 Urotech Devices Company Information, Head Office, Market Area and Industry Position
9.14.2 Urotech Devices Company Profile and Main Business
9.14.3 Urotech Devices Benign Prostatic Hyperplasia (BPH) Laser Therapy Models, Specifications and Application
9.14.4 Urotech Devices Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Gross Margin, 2018-2023
9.14.5 Urotech Devices Recent Developments
9.15 BD
9.15.1 BD Company Information, Head Office, Market Area and Industry Position
9.15.2 BD Company Profile and Main Business
9.15.3 BD Benign Prostatic Hyperplasia (BPH) Laser Therapy Models, Specifications and Application
9.15.4 BD Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Gross Margin, 2018-2023
9.15.5 BD Recent Developments
9.16 PROCEPT BioRobotics
9.16.1 PROCEPT BioRobotics Company Information, Head Office, Market Area and Industry Position
9.16.2 PROCEPT BioRobotics Company Profile and Main Business
9.16.3 PROCEPT BioRobotics Benign Prostatic Hyperplasia (BPH) Laser Therapy Models, Specifications and Application
9.16.4 PROCEPT BioRobotics Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Gross Margin, 2018-2023
9.16.5 PROCEPT BioRobotics Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Table 1. Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Restraints
Table 3. Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Trends
Table 4. Benign Prostatic Hyperplasia (BPH) Laser Therapy Industry Policy
Table 5. Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Mergers & Acquisitions, Expansion Plans
Table 9. Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Major Companies Product Type
Table 10. Head Office and Area Served of Key Players
Table 11. China Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 12. China Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue Market Share by Company, 2018-2023
Table 13. Global Key Players of Benign Prostatic Hyperplasia (BPH) Laser Therapy Upstream (Raw Materials)
Table 14. Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Typical Customers
Table 15. Benign Prostatic Hyperplasia (BPH) Laser Therapy Typical Distributors
Table 16. By Type, Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 17. By Application, Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 18. By Region, Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 19. By Region, Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value, 2018-2029, US$ Million
Table 20. By Country, Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 21. By Country, Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value, 2018-2029, US$ Million
Table 22. By Country, Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value Market Share, 2018-2029
Table 23. Boston Scientific Company Information, Head Office, Market Area and Industry Position
Table 24. Boston Scientific Company Profile and Main Business
Table 25. Boston Scientific Benign Prostatic Hyperplasia (BPH) Laser Therapy Models, Specifications, and Application
Table 26. Boston Scientific Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Gross Margin, US$ Million, 2018-2023
Table 27. Boston Scientific Recent Developments
Table 28. Agiliti Health, Inc. Company Information, Head Office, Market Area and Industry Position
Table 29. Agiliti Health, Inc. Company Profile and Main Business
Table 30. Agiliti Health, Inc. Benign Prostatic Hyperplasia (BPH) Laser Therapy Models, Specifications, and Application
Table 31. Agiliti Health, Inc. Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Gross Margin, US$ Million, 2018-2023
Table 32. Agiliti Health, Inc. Recent Developments
Table 33. Endo Pharmaceuticals Inc. Company Information, Head Office, Market Area and Industry Position
Table 34. Endo Pharmaceuticals Inc. Company Profile and Main Business
Table 35. Endo Pharmaceuticals Inc. Benign Prostatic Hyperplasia (BPH) Laser Therapy Models, Specifications, and Application
Table 36. Endo Pharmaceuticals Inc. Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Gross Margin, US$ Million, 2018-2023
Table 37. Endo Pharmaceuticals Inc. Recent Developments
Table 38. HealthTronics, Inc. Company Information, Head Office, Market Area and Industry Position
Table 39. HealthTronics, Inc. Company Profile and Main Business
Table 40. HealthTronics, Inc. Benign Prostatic Hyperplasia (BPH) Laser Therapy Models, Specifications, and Application
Table 41. HealthTronics, Inc. Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Gross Margin, US$ Million, 2018-2023
Table 42. HealthTronics, Inc. Recent Developments
Table 43. OmniGuide Company Information, Head Office, Market Area and Industry Position
Table 44. OmniGuide Company Profile and Main Business
Table 45. OmniGuide Benign Prostatic Hyperplasia (BPH) Laser Therapy Models, Specifications, and Application
Table 46. OmniGuide Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Gross Margin, US$ Million, 2018-2023
Table 47. OmniGuide Recent Developments
Table 48. Olympus Corporation Company Information, Head Office, Market Area and Industry Position
Table 49. Olympus Corporation Company Profile and Main Business
Table 50. Olympus Corporation Benign Prostatic Hyperplasia (BPH) Laser Therapy Models, Specifications, and Application
Table 51. Olympus Corporation Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Gross Margin, US$ Million, 2018-2023
Table 52. Olympus Corporation Recent Developments
Table 53. Richard Wolf GmbH Company Information, Head Office, Market Area and Industry Position
Table 54. Richard Wolf GmbH Company Profile and Main Business
Table 55. Richard Wolf GmbH Benign Prostatic Hyperplasia (BPH) Laser Therapy Models, Specifications, and Application
Table 56. Richard Wolf GmbH Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Gross Margin, US$ Million, 2018-2023
Table 57. Richard Wolf GmbH Recent Developments
Table 58. Lumenis Company Information, Head Office, Market Area and Industry Position
Table 59. Lumenis Company Profile and Main Business
Table 60. Lumenis Benign Prostatic Hyperplasia (BPH) Laser Therapy Models, Specifications, and Application
Table 61. Lumenis Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Gross Margin, US$ Million, 2018-2023
Table 62. Lumenis Recent Developments
Table 63. Urologix, LLC Company Information, Head Office, Market Area and Industry Position
Table 64. Urologix, LLC Company Profile and Main Business
Table 65. Urologix, LLC Benign Prostatic Hyperplasia (BPH) Laser Therapy Models, Specifications, and Application
Table 66. Urologix, LLC Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Gross Margin, US$ Million, 2018-2023
Table 67. Urologix, LLC Recent Developments
Table 68. Coloplast Corp Company Information, Head Office, Market Area and Industry Position
Table 69. Coloplast Corp Company Profile and Main Business
Table 70. Coloplast Corp Benign Prostatic Hyperplasia (BPH) Laser Therapy Models, Specifications, and Application
Table 71. Coloplast Corp Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Gross Margin, US$ Million, 2018-2023
Table 72. Coloplast Corp Recent Developments
Table 73. Medifocus Inc. Company Information, Head Office, Market Area and Industry Position
Table 74. Medifocus Inc. Company Profile and Main Business
Table 75. Medifocus Inc. Benign Prostatic Hyperplasia (BPH) Laser Therapy Models, Specifications, and Application
Table 76. Medifocus Inc. Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Gross Margin, US$ Million, 2018-2023
Table 77. Medifocus Inc. Recent Developments
Table 78. Biolitec Company Information, Head Office, Market Area and Industry Position
Table 79. Biolitec Company Profile and Main Business
Table 80. Biolitec Benign Prostatic Hyperplasia (BPH) Laser Therapy Models, Specifications, and Application
Table 81. Biolitec Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Gross Margin, US$ Million, 2018-2023
Table 82. Biolitec Recent Developments
Table 83. Teleflex Incorporated Company Information, Head Office, Market Area and Industry Position
Table 84. Teleflex Incorporated Company Profile and Main Business
Table 85. Teleflex Incorporated Benign Prostatic Hyperplasia (BPH) Laser Therapy Models, Specifications, and Application
Table 86. Teleflex Incorporated Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Gross Margin, US$ Million, 2018-2023
Table 87. Teleflex Incorporated Recent Developments
Table 88. Urotech Devices Company Information, Head Office, Market Area and Industry Position
Table 89. Urotech Devices Company Profile and Main Business
Table 90. Urotech Devices Benign Prostatic Hyperplasia (BPH) Laser Therapy Models, Specifications, and Application
Table 91. Urotech Devices Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Gross Margin, US$ Million, 2018-2023
Table 92. Urotech Devices Recent Developments
Table 93. BD Company Information, Head Office, Market Area and Industry Position
Table 94. BD Company Profile and Main Business
Table 95. BD Benign Prostatic Hyperplasia (BPH) Laser Therapy Models, Specifications, and Application
Table 96. BD Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Gross Margin, US$ Million, 2018-2023
Table 97. BD Recent Developments
Table 98. PROCEPT BioRobotics Company Information, Head Office, Market Area and Industry Position
Table 99. PROCEPT BioRobotics Company Profile and Main Business
Table 100. PROCEPT BioRobotics Benign Prostatic Hyperplasia (BPH) Laser Therapy Models, Specifications, and Application
Table 101. PROCEPT BioRobotics Benign Prostatic Hyperplasia (BPH) Laser Therapy Revenue and Gross Margin, US$ Million, 2018-2023
Table 102. PROCEPT BioRobotics Recent Developments
List of Figures
Figure 1. Benign Prostatic Hyperplasia (BPH) Laser Therapy Picture
Figure 2. Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value, (US$ million) & (2018-2029)
Figure 3. China Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value, (US$ million) & (2018-2029)
Figure 4. By Consumption Value, China Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Share of Global, 2018-2029
Figure 5. Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 6. China Benign Prostatic Hyperplasia (BPH) Laser Therapy Key Participants, Market Share, 2022
Figure 7. Benign Prostatic Hyperplasia (BPH) Laser Therapy Industry Chain
Figure 8. Benign Prostatic Hyperplasia (BPH) Laser Therapy Procurement Model
Figure 9. Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Model
Figure 10. Benign Prostatic Hyperplasia (BPH) Laser Therapy Sales Channels, Direct Sales, and Distribution
Figure 11. Holmium Laser
Figure 12. Thulium Laser
Figure 13. Green Light Laser
Figure 14. Others
Figure 15. By Type, Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value, 2018-2029, US$ Million
Figure 16. By Type, Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value Market Share, 2018-2029
Figure 17. Hospitals
Figure 18. Clinics
Figure 19. Others
Figure 20. By Application, Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value, 2018-2029, US$ Million
Figure 21. By Application, Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value Market Share, 2018-2029
Figure 22. By Region, Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value Market Share, 2018-2029
Figure 23. North America Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 24. By Country, North America Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value Market Share, 2022
Figure 25. Europe Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 26. By Country, Europe Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value Market Share, 2022
Figure 27. Asia Pacific Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 28. By Country/Region, Asia Pacific Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value Market Share, 2022
Figure 29. South America Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 30. By Country, South America Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value Market Share, 2022
Figure 31. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 32. U.S. Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value, 2018-2029, US$ Million
Figure 33. By Type, U.S. Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value Market Share, 2022 VS 2029
Figure 34. By Application, U.S. Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value Market Share, 2022 VS 2029
Figure 35. Europe Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value, 2018-2029, US$ Million
Figure 36. By Type, Europe Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value Market Share, 2022 VS 2029
Figure 37. By Application, Europe Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value Market Share, 2022 VS 2029
Figure 38. China Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value, 2018-2029, US$ Million
Figure 39. By Type, China Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value Market Share, 2022 VS 2029
Figure 40. By Application, China Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value Market Share, 2022 VS 2029
Figure 41. Japan Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value, 2018-2029, US$ Million
Figure 42. By Type, Japan Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value Market Share, 2022 VS 2029
Figure 43. By Application, Japan Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value Market Share, 2022 VS 2029
Figure 44. South Korea Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value, 2018-2029, US$ Million
Figure 45. By Type, South Korea Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value Market Share, 2022 VS 2029
Figure 46. By Application, South Korea Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value Market Share, 2022 VS 2029
Figure 47. Southeast Asia Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value, 2018-2029, US$ Million
Figure 48. By Type, Southeast Asia Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value Market Share, 2022 VS 2029
Figure 49. By Application, Southeast Asia Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value Market Share, 2022 VS 2029
Figure 50. India Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value, 2018-2029, US$ Million
Figure 51. By Type, India Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value Market Share, 2022 VS 2029
Figure 52. By Application, India Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value Market Share, 2022 VS 2029
Figure 53. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value, 2018-2029, US$ Million
Figure 54. By Type, Middle East & Africa Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value Market Share, 2022 VS 2029
Figure 55. By Application, Middle East & Africa Benign Prostatic Hyperplasia (BPH) Laser Therapy Consumption Value Market Share, 2022 VS 2029
Figure 56. Research Methodology
Figure 57. Breakdown of Primary Interviews
Figure 58. Bottom-up and Top-down Approaches
Figure 59. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
Historical Data (2015-2019) |
|
|
Influencing Factors |
|
|
Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|